Abstract: Provided is an immunogenic composition including a peptide, wherein consecutive amino acids of the peptide include at least amino acids 186-193 of SEQ ID NO:1 and one or more adjuvants. In an example, the peptide is covalently linked to an amino acid sequence including SEQ ID NO:2. Also provided is a method of vaccinating a subject against Borrelia burgdorferi, including administering to the subject an effective amount of the immunogenic composition.
Type:
Grant
Filed:
March 28, 2022
Date of Patent:
October 3, 2023
Assignees:
HEALTH RESEARCH, INC., LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTER
Abstract: Provided is an immunogenic composition including a peptide, wherein consecutive amino acids of the peptide include at least amino acids 186-193 of SEQ ID NO:1 and one or more adjuvants. In an example, the peptide is covalently linked to an amino acid sequence including SEQ ID NO:2.
Type:
Grant
Filed:
December 21, 2018
Date of Patent:
June 30, 2020
Assignees:
HEALTH RESEARCH, INC., LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTER